Lattime E C, Mastrangelo M J, Bagasra O, Li W, Berd D
Department of Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Cancer Immunol Immunother. 1995 Sep;41(3):151-6. doi: 10.1007/BF01521340.
We have reported that patients with metastatic melanoma treated with an autologous, dinitrophenol-modified vaccine develop inflammatory responses at tumor sites. Histologically, these inflamed lesions are characterized by T cell infiltration, which is sometimes associated with tumor cell destruction. We tested biopsy specimens of eight subcutaneous metastases that had developed inflammation following vaccine treatment for expression of mRNA for interferon gamma (IFN gamma), interleukin-4 (IL-4), tumor necrosis factor alpha (TNF alpha), and IL-10. Post-vaccine, inflamed biopsies contained mRNA for IFN gamma (5/8), IL-4 (4/8) or both (3/8), and for TNF alpha (4/7). In contrast, IFN gamma mRNA was detected in only 1/17 and TNF alpha mRNA in 2/16 control specimens (pre-treatment lymph node metastases or non-inflamed subcutaneous metastases). mRNA for IL-10, a cytokine with anti-inflammatory properties, was detected in 24/25 melanoma metastases and was independent of lymphoid content; in situ the reverse transcriptase/polymerase chain reaction confirmed that melanoma cells were the major source. These findings may provide a new parameter by which to measure the effects of cancer immunotherapy.
我们曾报道,接受自体二硝基苯酚修饰疫苗治疗的转移性黑色素瘤患者在肿瘤部位会产生炎症反应。从组织学上看,这些炎症病变的特征是T细胞浸润,有时还伴有肿瘤细胞破坏。我们检测了8个在疫苗治疗后出现炎症的皮下转移灶的活检标本,以检测干扰素γ(IFNγ)、白细胞介素-4(IL-4)、肿瘤坏死因子α(TNFα)和IL-10的mRNA表达。疫苗治疗后,炎症活检标本中含有IFNγ(5/8)、IL-4(4/8)或两者都有(3/8)的mRNA,以及TNFα(4/7)的mRNA。相比之下,在仅1/17的对照标本(治疗前淋巴结转移灶或无炎症的皮下转移灶)中检测到IFNγ mRNA,在2/16的对照标本中检测到TNFα mRNA。抗炎细胞因子IL-10的mRNA在24/25的黑色素瘤转移灶中被检测到,且与淋巴细胞含量无关;原位逆转录酶/聚合酶链反应证实黑色素瘤细胞是主要来源。这些发现可能提供一个衡量癌症免疫治疗效果的新参数。